Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Andreas P. Wagner sold 14,878 shares of the business's stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $14.38, for a total value of $213,945.64. Following the sale, the insider now directly owns 200,885 shares in the company, valued at $2,888,726.30. This trade represents a 6.90 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Alignment Healthcare Price Performance
NASDAQ:ALHC opened at $14.52 on Thursday. The firm has a market cap of $2.78 billion, a price-to-earnings ratio of -18.86 and a beta of 1.50. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $15.82. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The company's 50-day moving average is $12.88 and its two-hundred day moving average is $11.54.
Hedge Funds Weigh In On Alignment Healthcare
Several institutional investors and hedge funds have recently modified their holdings of the company. Cinctive Capital Management LP purchased a new stake in Alignment Healthcare in the 4th quarter worth approximately $336,000. Franklin Resources Inc. acquired a new stake in shares of Alignment Healthcare during the fourth quarter worth $732,000. Alliancebernstein L.P. grew its position in shares of Alignment Healthcare by 2.8% in the fourth quarter. Alliancebernstein L.P. now owns 119,440 shares of the company's stock valued at $1,344,000 after purchasing an additional 3,300 shares during the period. Wellington Management Group LLP increased its stake in Alignment Healthcare by 77.9% in the fourth quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company's stock valued at $83,683,000 after purchasing an additional 3,257,630 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its position in Alignment Healthcare by 133.5% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 147,478 shares of the company's stock worth $1,659,000 after buying an additional 84,315 shares during the period. Hedge funds and other institutional investors own 86.19% of the company's stock.
Analysts Set New Price Targets
Several equities analysts recently issued reports on ALHC shares. Stephens reaffirmed an "overweight" rating and set a $17.00 price objective on shares of Alignment Healthcare in a report on Thursday, January 2nd. UBS Group lifted their price target on Alignment Healthcare from $9.00 to $12.00 and gave the stock a "neutral" rating in a research note on Wednesday, October 30th. Barclays increased their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an "underweight" rating in a research note on Wednesday, October 30th. Finally, Stifel Nicolaus lifted their target price on shares of Alignment Healthcare from $14.00 to $16.00 and gave the stock a "buy" rating in a research report on Tuesday, January 14th. One research analyst has rated the stock with a sell rating, two have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $11.88.
Get Our Latest Report on Alignment Healthcare
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
